Nuvo Pharmaceuticals Inc
TSX:MRV
Nuvo Pharmaceuticals Inc
TSX:MRV
Price:
1.35 CAD
Market Closed
Updated:
May 5, 2024
Nuvo Pharmaceuticals Inc
Cash from Financing Activities
|
Nuvo Pharmaceuticals Inc
Cash from Financing Activities Peer Comparison
Comparables:
BHC
WEED
CRON
C
CURA
T
TER
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
Cash from Financing Activities
-CA$13.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cash from Financing Activities
$1.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Cash from Financing Activities
-CA$347.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Cash from Financing Activities
-$1m
|
CAGR 3-Years
43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Cash from Financing Activities
-$22.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Terrascend Corp
CNSX:TER
|
Cash from Financing Activities
$10.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Nuvo Pharmaceuticals Inc's Cash from Financing Activities?
Cash from Financing Activities
-13.3m
CAD
-13.3m
CAD
Based on the financial report for Sep 30, 2022, Nuvo Pharmaceuticals Inc's Cash from Financing Activities amounts to -13.3m CAD.
What is Nuvo Pharmaceuticals Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
6%
6%
Over the last year, the Cash from Financing Activities growth was 6%.
You don't have any saved screeners yet
